3/20
11:06 am
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
3/20
11:06 am
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
3/20
10:55 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
3/20
10:55 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
3/20
09:58 am
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $30.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $30.00 price target on the stock.
3/20
09:58 am
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $30.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $30.00 price target on the stock.
3/20
09:51 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
3/20
09:29 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
3/20
09:29 am
imnm
Rating for IMNM
Low
Report
Rating for IMNM
3/10
12:14 pm
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
3/10
12:14 pm
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Low
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
1/13
06:17 pm
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Medium
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
1/13
06:17 pm
imnm
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.
Medium
Report
Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.